BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 31697830)

  • 1. Genetic Modifiers of Cystic Fibrosis-Related Diabetes Have Extensive Overlap With Type 2 Diabetes and Related Traits.
    Aksit MA; Pace RG; Vecchio-Pagán B; Ling H; Rommens JM; Boelle PY; Guillot L; Raraigh KS; Pugh E; Zhang P; Strug LJ; Drumm ML; Knowles MR; Cutting GR; Corvol H; Blackman SM
    J Clin Endocrinol Metab; 2020 May; 105(5):1401-15. PubMed ID: 31697830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pleiotropic modifiers of age-related diabetes and neonatal intestinal obstruction in cystic fibrosis.
    Aksit MA; Ling H; Pace RG; Raraigh KS; Onchiri F; Faino AV; Pagel K; Pugh E; Stilp AM; Sun Q; Blue EE; Wright FA; Zhou YH; Bamshad MJ; Gibson RL; Knowles MR; Cutting GR; Blackman SM;
    Am J Hum Genet; 2022 Oct; 109(10):1894-1908. PubMed ID: 36206743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic modifiers of cystic fibrosis-related diabetes.
    Blackman SM; Commander CW; Watson C; Arcara KM; Strug LJ; Stonebraker JR; Wright FA; Rommens JM; Sun L; Pace RG; Norris SA; Durie PR; Drumm ML; Knowles MR; Cutting GR
    Diabetes; 2013 Oct; 62(10):3627-35. PubMed ID: 23670970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Concepts in the Pathogenesis of Cystic Fibrosis-Related Diabetes.
    Moheet A; Moran A
    J Clin Endocrinol Metab; 2022 May; 107(6):1503-1509. PubMed ID: 35106591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystic fibrosis-related diabetes onset can be predicted using biomarkers measured at birth.
    Lin YC; Keenan K; Gong J; Panjwani N; Avolio J; Lin F; Adam D; Barrett P; Bégin S; Berthiaume Y; Bilodeau L; Bjornson C; Brusky J; Burgess C; Chilvers M; Consunji-Araneta R; Côté-Maurais G; Dale A; Donnelly C; Fairservice L; Griffin K; Henderson N; Hillaby A; Hughes D; Iqbal S; Itterman J; Jackson M; Karlsen E; Kosteniuk L; Lazosky L; Leung W; Levesque V; Maille É; Mateos-Corral D; McMahon V; Merjaneh M; Morrison N; Parkins M; Pike J; Price A; Quon BS; Reisman J; Smith C; Smith MJ; Vadeboncoeur N; Veniott D; Viczko T; Wilcox P; van Wylick R; Cutting G; Tullis E; Ratjen F; Rommens JM; Sun L; Solomon M; Stephenson AL; Brochiero E; Blackman S; Corvol H; Strug LJ
    Genet Med; 2021 May; 23(5):927-933. PubMed ID: 33500570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic fibrosis-related diabetes before lung transplantation is associated with lower survival but does not affect long-term renal function.
    Mainbourg S; Philit F; Touzet S; Nove-Josserand R; Durupt S; Sénéchal A; Occelli P; Poupon-Bourdy S; Maury JM; Tronc F; Mornex JF; Durieu I; Reynaud Q
    Pediatr Pulmonol; 2019 Jul; 54(7):977-983. PubMed ID: 30854801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose intolerance in cystic fibrosis patients.
    Lanng S
    Paediatr Respir Rev; 2001 Sep; 2(3):253-9. PubMed ID: 12052327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Islet Interleukin-1β Immunoreactivity Is an Early Feature of Cystic Fibrosis That May Contribute to β-Cell Failure.
    Hull RL; Gibson RL; McNamara S; Deutsch GH; Fligner CL; Frevert CW; Ramsey BW; Sanda S
    Diabetes Care; 2018 Apr; 41(4):823-830. PubMed ID: 29437698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis].
    Khammar A; Stremler N; Dubus JC; Gross G; Sarles J; Reynaud R
    Arch Pediatr; 2009 Dec; 16(12):1540-6. PubMed ID: 19854630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of genetic modifiers, inflammation and CFTR in the pathogenesis of Cystic fibrosis related diabetes.
    Hasan S; Soltman S; Wood C; Blackman SM
    J Clin Transl Endocrinol; 2022 Mar; 27():100287. PubMed ID: 34976741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of anion transporter SLC26A9 delays diabetes onset in cystic fibrosis.
    Lam AN; Aksit MA; Vecchio-Pagan B; Shelton CA; Osorio DL; Anzmann AF; Goff LA; Whitcomb DC; Blackman SM; Cutting GR
    J Clin Invest; 2020 Jan; 130(1):272-286. PubMed ID: 31581148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staphylococcus aureus and Pseudomonas aeruginosa co-infection is associated with cystic fibrosis-related diabetes and poor clinical outcomes.
    Limoli DH; Yang J; Khansaheb MK; Helfman B; Peng L; Stecenko AA; Goldberg JB
    Eur J Clin Microbiol Infect Dis; 2016 Jun; 35(6):947-53. PubMed ID: 26993289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MARKEDLY DELAYED INSULIN SECRETION AND A HIGH RATE OF UNDETECTED OVERT DIABETES CHARACTERIZE GLUCOSE METABOLISM IN ADULT PATIENTS WITH CYSTIC FIBROSIS AFTER LUNG TRANSPLANTATION.
    Winhofer Y; Wolf P; Fellinger P; Tura A; Hillebrand P; Staufer K; Trauner M; Jaksch P; Muraközy G; Kautzky-Willer A; Pacini G; Krebs M; Luger A; Kazemi-Shirazi L
    Endocr Pract; 2019 Mar; 25(3):254-262. PubMed ID: 30913015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic Fibrosis-Related Diabetes in Poland.
    Rachel M; Biesiadecki M; Galiniak S
    Int J Environ Res Public Health; 2022 Mar; 19(7):. PubMed ID: 35409752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Potential Causes of Cystic Fibrosis-Related Diabetes.
    Coderre L; Debieche L; Plourde J; Rabasa-Lhoret R; Lesage S
    Front Endocrinol (Lausanne); 2021; 12():702823. PubMed ID: 34394004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystic fibrosis-related diabetes is caused by islet loss and inflammation.
    Hart NJ; Aramandla R; Poffenberger G; Fayolle C; Thames AH; Bautista A; Spigelman AF; Babon JAB; DeNicola ME; Dadi PK; Bush WS; Balamurugan AN; Brissova M; Dai C; Prasad N; Bottino R; Jacobson DA; Drumm ML; Kent SC; MacDonald PE; Powers AC
    JCI Insight; 2018 Apr; 3(8):. PubMed ID: 29669939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystic Fibrosis-Related Diabetes Workshop: Research Priorities Spanning Disease Pathophysiology, Diagnosis, and Outcomes.
    Putman MS; Norris AW; Hull RL; Rickels MR; Sussel L; Blackman SM; Chan CL; Ode KL; Daley T; Stecenko AA; Moran A; Helmick MJ; Cray S; Alvarez JA; Stallings VA; Tuggle KL; Clancy JP; Eggerman TL; Engelhardt JF; Kelly A
    Diabetes; 2023 Jun; 72(6):677-689. PubMed ID: 37125945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The course of glucose intolerance in children with cystic fibrosis: a retrospective study - preliminary report.
    Piechowiak K; Trippenbach-Dulska H; Walicka-Serzysko K
    Dev Period Med; 2015; 19(1):80-91. PubMed ID: 26003073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing diabetes in cystic fibrosis.
    Laguna TA; Nathan BM; Moran A
    Diabetes Obes Metab; 2010 Oct; 12(10):858-64. PubMed ID: 20920037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystic fibrosis related diabetes mellitus - diagnostic and management challenges.
    Lek N; Acerini CL
    Curr Diabetes Rev; 2010 Jan; 6(1):9-16. PubMed ID: 20034372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.